Department of Intensive Care Unit, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Ann Palliat Med. 2022 May;11(5):1649-1659. doi: 10.21037/apm-21-2352. Epub 2021 Dec 27.
A great increase in the number of patients needs critical care to the intensive care unit (ICU) due to improvements in oncology. The aim of the study was to explore risk factors affecting survival of critically ill patients with solid cancers in ICU.
The study retrospectively reviewed patients between 2001 and 2012, which were collected by Medical Information Mart for Intensive Care III (MIMIC-III) from the Beth Israel Deaconess Medical Center in Boston, MA, USA.
A total of 38,508 adult patients, who were admitted to ICUs and 8,308 (21.6%) were diagnosed as an underlying malignancy; 1,671 and 3,165 adult patients with sold cancer were admitted to surgical ICU (SICU) and medical ICU (MICU), respectively. Patients in SICU had a higher survival rate at the point of 28-, 90-day, and 1-, 3-year than patients in MICU (P<0.001 for all). Multivariate analysis demonstrated that age ≥70, emergency admission, the presence of metastases, Oxford Acute Severity of Illness Score (OASIS) ≥30 and sepsis were independent risk factors affecting 28-day survival in SICU. In MICU, emergency admission, metastatic disease, Sequential Organ Failure Assessment (SOFA) ≥3, Simplified Acute Physiology Score II (SAPS II) ≥39, Acute Physiology Score III (APS III) ≥40, Oxford Acute Severity of Illness Score (OASIS) ≥30, Elixhauser comorbidity index ≥9 and sepsis were independent risk factors for 28-day survival rate. The area under curve (AUC) of the OASIS for predicting ICU mortality was 0.824 [95% confidence interval (CI): 0.805-0.842], which was obviously higher than other scores in SICU. The AUC of the SAPS II for predicting ICU mortality was 0.820 (95% CI: 0.806-0.833), which was slightly higher than other scores in MICU.
Patients with cancer in SICU have longer survival time than patients with cancer in MICU. The prediction of prognosis of critically ill cancer patients can guide treatment and optimize medical resources.
由于肿瘤学的进步,需要重症监护的癌症患者数量大量增加,进入重症监护病房(ICU)。本研究旨在探讨影响 ICU 中实体癌危重病患者生存的危险因素。
本研究回顾性分析了 2001 年至 2012 年间美国马萨诸塞州波士顿贝斯以色列女执事医疗中心的医学信息集市 III(MIMIC-III)收集的数据。
共有 38508 名成年患者入住 ICU,其中 8308 例(21.6%)被诊断为潜在恶性肿瘤;1671 例和 3165 例成年实体癌患者分别入住外科 ICU(SICU)和内科 ICU(MICU)。SICU 患者在 28 天、90 天、1 年和 3 年的生存率均高于 MICU 患者(所有 P<0.001)。多因素分析表明,年龄≥70 岁、急诊入院、存在转移、牛津急性疾病严重程度评分(OASIS)≥30 分和脓毒症是影响 SICU 患者 28 天生存率的独立危险因素。在 MICU 中,急诊入院、转移性疾病、序贯器官衰竭评估(SOFA)≥3 分、简化急性生理学评分 II(SAPS II)≥39 分、急性生理学评分 III(APS III)≥40 分、牛津急性疾病严重程度评分(OASIS)≥30 分、Elixhauser 合并症指数≥9 分和脓毒症是影响 28 天生存率的独立危险因素。OASIS 预测 ICU 死亡率的曲线下面积(AUC)为 0.824[95%置信区间(CI):0.805-0.842],明显高于 SICU 中的其他评分。SAPS II 预测 ICU 死亡率的 AUC 为 0.820(95%CI:0.806-0.833),略高于 MICU 中的其他评分。
SICU 中的癌症患者比 MICU 中的癌症患者存活时间更长。危重病癌症患者预后的预测可以指导治疗并优化医疗资源。